GC Rieber VivoMega announces completion of its facility expansion ahead of schedule
The $75 million facility expansion allows the company to double its output of the triglyceride form of marine omega-3s EPA and DHA and certified vegan EPA & DHA algal oils.
GC Rieber facility. Images courtesy of the company.
GC Rieber VivoMega (Norway) has announced the completion and grand opening of its new omega-3 manufacturing facility in Norway. The grand opening took place on May 24, 2024. The new facility allows the company to double its output of the triglyceride form of marine omega-3s EPA and DHA and certified vegan EPA & DHA algal oils.
The $75 million investment, originally announced in May of 2022, included:
- A 38,000 metric ton storage tank park
- An electric steam boiler allowing its three facilities to run on 100% renewable energy
- Additional heating capabilities to help maintain the quality of the oils and allow for easier extraction in winter
- Additional nitrogen to remove oxygen for improved sensory profiles
“This is an exciting time for GC Rieber VivoMega and our customers,” said Snorre Glærum Strand, CEO at GC Rieber VivoMega, in a press release. “With the supply of fish oils starting to normalize somewhat thanks to improvements in ongoing fishery, and the growing demand for sustainable, traceable, high-quality omega-3 increases, this new facility allows us to meet the varying consumer needs, including a vegan alternative EPA & DHA.”
Strand explains that the company minimized its ecological footprint by utilizing some of the existing infrastructure, including docks, tanks, and laboratories. The improved campus aligns with EU Green Deal initiatives and the UN Global Compact guidelines. GC Rieber VivoMega is also SEDEX-certified. According to the company, the expansion makes GC Rieber the world’s largest fish and algae manufacturing storage facility.
Updated June 17, 2024 at 10:09 AM EST
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
